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Background: The etiopathogenesis of gallbladder cancer is still unknown. Both environmental and patient factors
have been incriminated in its cause. That it is found in pockets of epidemiological distribution raises an issue of
genetic changes associated with it. The aim of this study was to find out the chromosomal changes in gallbladder
cancer.
Methods: Lymphocyte cell culture was carried out on blood of gallbladder cancer patients to determine
chromosomal banding abnormalities. Native PAGE was also evaluated to analyze lactate dehydrogenase (LDH),
superoxide dismutase (SOD) and catalase enzyme activity from the same blood of gallbladder cancer patients.
Results: Out of 30 gallbladder cancer patients, 4 male showed breakage on the long arm of chromosome 1 while
only one male patient showed the translocation from the long arm of chromosome 4 to the long arm of
chromosome 6 in a male patient.
Conclusion: The aberrations found in our study may suggest underlying genetic predisposition for the
development of gallbladder cancer. They can act as a marker for gallbladder cancer, which needs further study.
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Carcinoma of the gallbladder (CaGB) is the most com-
mon malignancy of the biliary tract and represents 2% of
all cancers. It is the third most common gastrointestinal
malignancy in northern India [1]. Although a lethal dis-
ease and known for decades, its exact etiopathogenesis
still eludes physicians. Its cause is thought to be multi-
factorial with involvement of both environmental and
patient factors, such as chronic cholecystitis, gallstones,
choledochal cysts, female gender, age and exposure to
carcinogens; but a definite cause-effect relationship is
yet to be established [2]. That it is found in pockets of
epidemiological distribution raises an issue of genetic or
chromosomal factors associated with it. The exact se-
quence of the molecular changes that lead to neoplastic
transformation in the gallbladder epithelium remains
uncertain. There is limited information available about
the molecular abnormalities involved in its pathogenesis.* Correspondence: vkshuklabhu@gmail.com
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cinogenesis during the development and progression of
gallbladder cancer [3]. Previous studies have identified
the presence of regions of frequent allele loss, involving
loss of heterozygosity (LOH) in the chromosomes of
gallbladder cancer patients [3], especially in the 3p, 8p,
9q and 22q chromosomal regions [4].
Multiple pathways control the accurate duplication and
distribution of DNA to progeny cells while other path-
ways control regulatory modifications of DNA during
normal development. These are known as the genetic
stability functions [5]. Genetic instability is considered to
be the root cause of the phenotypic and genotypic vari-
ation between the different cell populations of a tumor
[6]. We hypothesized that CaGB in Indian patients may
be associated with chromosomal changes, which may
lead to a better understanding of a correlation between
the two. The aim of the present work is to find out the
chromosomal changes in gallbladder cancer and to iden-
tify the most consistent changes involved in the patho-
genesis of gallbladder cancer.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
Thirty newly diagnosed cases of gallbladder cancer,
which had not yet undergone any treatment in the form
of surgery, chemotherapy and radiotherapy, were
included consecutively in the study from September
2007 to July 2009 after obtaining informed consent from
the patients. This was a single institution study. Histo-
pathological or cytological diagnosis was obtained before
inclusion in the study. This study was approved by the
institution’s ethics committee.
A venous blood sample (2 mL) was collected from
each patient using heparin as an anticoagulant, and
chromosomal analysis was carried out in the Biochemis-
try and Molecular Biology lab, Department of Zoology,
Faculty of Sciences of our university.
Lymphocyte culture
The collected blood samples were centrifuged at
3,000 rpm for five minutes. Pellets from the centrifuged
blood were discarded and the “buffy coat” was taken for
lymphocyte culture. Lymphocyte culture was set in 7 ml
of RPMI (Roswell Park Memorial Institute) 1640 media
with 10% FBS (fetal bovine serum) as the nutrient in a
sterile culture tube. A total of 100 μl of PHA-M (Phyto-
hemagglutinin-M-5 mg/ml-Himedia) was added in the
tube as a mitogen with 0.5 ml of lymphocyte culture.
The culture was incubated for 72 hrs in a CO2 incubator
at 37°C with 5% CO2.
A total of 4 μl of colchicine (1 mg/ml; Himedia) was
added before harvesting at the 69th hour to arrest the
chromosome in the metaphase stage. The culture was
harvested at the 72nd hour and centrifuged at 2,200 rpm
for five minutes and the supernatant was discarded. Pre-
warmed (37°C) hypotonic solution (0.56% of KCl-Merck)
was added to the pellets and kept in an incubator for
20 minutes at 37°C to swell the cells and spread the
chromosomes. After hypotonic treatment, it was centri-
fuged again at 2,200 rpm for five minutes; the super-
natant was discarded and 5 ml of Carney’s fixative (3:1,
methanol: glacial acetic acid) was added drop by drop.
The pellet was agitated vigorously and resuspended in
fixative. This was repeated three times. Finally, the pellet
was resuspended in 0.5 ml of fixative. Suspension was
splashed (forcing the chromosomes into a single plane)
on chilled slides and was flame dried.
Slides with good chromosome preparation were
selected. One ml of trypsin stock solution (30 mg/ml)
was made up to 50 ml with 0.9% sodium chloride in a
coupling jar (pH 7.5 to 7.8). The slides were stained in
Giemsa for three to five minutes, rinsed in H2O and
observed under a microscope.
Native polyacrylamide gel (8%) electrophoresis was
performed to analyze the lactate dehydrogenase (LDH),superoxide dismutase (SOD) and catalase enzyme activ-
ity in the blood of the gallbladder cancer patients. Elec-
trophoresis was carried out at 4°C for three hours,
applying a voltage of 10 mV. The gel was stained for a
specific enzyme, that is, LDH, catalase and SOD.
a) LDH activity: To analyze the activity of LDH, the
gels were stained with LDH specific stain. LDH
specific staining was done according to the method
of Worthington with modification [7]. The staining
solution of LDH consists of 0.1 M Tris-Cl (2-amino-
2-hydroxymethyl-propane-1,3-diol- HCl) buffer (pH
8.4), 1 mg/ml nicotinamide adenine dinucleotide
(NAD+), 0.5 mg/ml nitroblue tetrazolium (NBT),
0.1 mg/ml phenozine methosulphate (PMS) and
0.05 M lithium lactate.
b)Catalase activity: The activity of catalase in
gallbladder cancer was performed by staining the gel
with catalase specific stain. The stain contains 0.03%
hydrogen peroxide, 0.2% potassium ferricynide and
0.2% ferric chloride [8].
c) SOD Activity: Similarly, the SOD activity in the
blood was analyzed by staining the gels with SOD
specific stain. The stain contained phosphate buffer
0.1 M (pH 7.4), 2.3 mM NBT (nitroblue
tetrazolium), 28 μM, riboflavin and 28 mM N N
N N’ tetramethyelenediamine (TEMED) [9].Results
The study was performed with 30 cases of histologically
confirmed carcinoma of the gallbladder. The mean age
of the patients was 49.9 ± 10.59 years. Out of 30 selected
patients 23.3% (7) were males and 76.7% (23) were
females. The sex ratio was 3.3:1 (female:male). The per-
ipheral lymphocyte metaphase plate stained with Giemsa
stain showed a male metaphase plate carrying 44, XY
but no chromosomal aberration was detected (Figure 1).
A normal pattern of chromosome distribution was found
on the karyotype. Out of 30 patients, 4 male showed
breakage at the long arm of chromosome 1 (Figure 2a,
b). One male patient showed translocation from the long
arm of chromosome 4 to the long arm of chromosome 6
(Figure 3). Patients having such aberrations were histolo-
gically proven to have adenocarcinoma. Five patients
who showed chromosomal aberrations all had well dif-
ferentiated tumors.Activity of LDH and antioxidant in gallbladder cancer
The serum showed high activity of LDH2 in gallbladder
cancer, which is the prominent form in serum. Concen-
trations of LDH3, LDH4 and LDH5 were also elevated
in gallbladder cancer (Figure 4). Increased activity of
antioxidant enzymes, such as catalase, was observed
Figure 1 The metaphase plate shows the chromosomes in a
normal male. It shows the all 44, XY chromosomes.
Figure 3 This figure shows the translocation from the long arm
of chromosome 4 to the long arm of chromosome 6 in a male
patient.
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bladder cancer.
Discussion
Carcinoma of the gallbladder is a lethal disease of the
biliary tract [6]. The epidemiological distribution of this
disease suggests that the presence of genetic, nutritional
and environmental factors may play roles in the etio-
pathogenesis of the malignancy [10]. The incidence rate
of gallbladder cancer varies and is confined to selected
pockets in India, Korea, Japan, Czech Republic, Slovakia,a
Figure 2 a. Figure shows the breakage of long arm of chromosome 1
arm of chromosome 1 in a male patient.Spain, Colombia, Chile, Peru, Bolivia and Ecuador [10].
This wide difference in incidence rate indicates a prob-
able strong association of this malignancy with genetic
factors that are common to the affected populations.
Acquired or inherent genetic instability in normal cells
causes mutational events that result in neoplastic trans-
formation and provide such cells with a selective growth
advantage over normal cells. These genetic instabilities
can be traced early by analysis of the chromosomal
banding pattern in the cancer patients, which addresses
the genetic instabilities associated with various cancersb
in a male patient. b. Image showing the breakage of the long
Figure 4 Native PAGE (8%) showing enzyme activity of lactate
dehydrogenase (LDH) in the serum of gallbladder cancer
patients.
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tions may be evident in any type of cancer [11] and it was
proved in case of endometrial carcinoma where 4% meta-
phase plates of peripheral blood lymphocytes were posi-
tive for the chromosome breakage. Similarly, peripheral
blood cultures of patients with breast cancer, malignant
melanoma, colon cancer, renal cell carcinoma or lung
cancer have shown simple chromosomal breaks that were
also marker chromosomes for their respective tumors
[12]. Therefore, peripheral blood lymphocyte cultures can
be a useful tool for demonstration of simple chromo-
somal lesions of cancer cells. The specific chromosomal
anomalies that can be easily picked up in peripheral blood
can act as an important marker for the disease.
In the present study, we have examined the peripheral
blood of gallbladder cancer patients for chromosomal
banding abnormalities on lymphocytes cell culture. Out
of 30 cases, 5 (16.6%) cases showed chromosomalaberrations. The simple aberrations were observed in
four patients. These aberrations were confined on
chromosome 1’s long arm. Another aberration was a
translocation from the long arm of chromosome 4 to the
long arm of chromosome 6. An interesting observation
is that all the aberrations were present in the male
karyotype. The cause of this breakage in chromosomes
of gallbladder patients is unknown, but its association
with gallbladder carcinoma is suggested. It may be due
to environmental effects, infections and inflammation
but further work is needed to establish a definite relation
between these aberrations and gallbladder cancer. The
prevalence of aberrations in our study is quite high, that
is, 16.6%. So, we can presume that this will help to find
the correlation between such aberrations and gallbladder
cancer. Further research will clarify an understanding of
the role of chromosomal anomalies in CaGB.
Previous reports had attempted to establish the signifi-
cance of chromosomal structural changes in various can-
cer types. But this kind of study has not been reported
in gallbladder cancer to date. Our study and some previ-
ous reports suggest an association of a chromosomal ab-
erration in gallbladder cancer [13].
The isoforms of LDH activity also increased in cases
of hepatobiliary malignancy [7]. Earlier studies also sug-
gest higher production of total LDH by tumor cells [14].
The serum level of catalase was elevated in the patients
with gallbladder cancer in our study. The isoforms of
SOD, such as Mn-SOD and Cu-Zn-SOD in gallbladder
cancer, show differential modulation.
The present study supports the hypothesis that genetic
mutation may be studied at a chromosomal level in gall-
bladder carcinoma. Conversely, specific chromosomal
aberrations may act as markers of gallbladder cancer.
Their manifestation in peripheral blood may be of diag-
nostic value in this disease with its poor prognosis.
Conclusion
This study was an attempt to look into the chromosomal
changes of gallbladder cancer and to identify those
changes by the use of cytogenetics. Chromosomal
changes in CaGB have not been done before by G- band-
ing or using the karyotype of the chromosome of periph-
eral blood lymphocyte culture. This allows a look inside
the complex world of genetic changes in gallbladder can-
cer. The simple aberrations in the form of breakage and
translocation may suggest underlying genetic predispos-
ition for development of carcinoma of the gallbladder
with proper correlation. These aberrations may also act
as a marker for gallbladder cancer and need further
study.
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